IDDF2022-ABS-0088 Peptostreptococcus anaerobius drives immune suppression and immune therapy resista...
IDDF2022-ABS-0088 Peptostreptococcus anaerobius drives immune suppression and immune therapy resistance in colorectal cancer
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Society of Gastroenterology
Subjects
More information
Scope and Contents
Contents
BackgroundThe gut microbiome plays a crucial role in cancer progression and treatment through shaping the tumor immune microenvironment (TIME). Here, we investigated the effect of P. anaerobius on the TIME, its molecular mechanism of action, and the impact of P. anaerobius on the efficacy of immune checkpoint blockade (ICB) therapy.MethodsThe effec...
Alternative Titles
Full title
IDDF2022-ABS-0088 Peptostreptococcus anaerobius drives immune suppression and immune therapy resistance in colorectal cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2711022978
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2711022978
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2022-IDDF.1
